Literature DB >> 11028485

Expression of tumor necrosis factor-alpha--converting enzyme and tumor necrosis factor-alpha in human myocarditis.

M Satoh1, M Nakamura, H Satoh, H Saitoh, I Segawa, K Hiramori.   

Abstract

OBJECTIVES: We determined whether tumor necrosis factor-alpha-converting enzyme (TACE) is expressed with tumor necrosis factor-alpha (TNF-alpha) in myocarditis.
BACKGROUND: Tumor necrosis factor-alpha-converting enzyme, which has recently been identified as belonging to the family of metalloproteinase disintegrin proteins, is responsible for the conversion of TNF-alpha precursor to its mature form.
METHODS: We examined TACE and TNF-alpha expressions in endomyocardial biopsy tissues obtained from 14 patients with myocarditis and five control subjects by using quantitative reverse transcriptase polymerase chain reaction and immunohistochemistry.
RESULTS: Expression of TNF-alpha and TACE messenger ribonucleic acid (mRNA) was significantly greater in the myocarditis group than in the control group. A positive correlation was found between TNF-alpha and TACE mRNAs (r = 0.83, p < 0.05). Six patients with severe myocarditis underwent repeat biopsies. Although TNF-alpha and TACE mRNAs were expressed at high levels in the initial biopsies, a marked decrease was noted in the repeat biopsies. The immunostainings for TNF-alpha and TACE were positive in the myocytes and interstitial cells of myocardium obtained from patients with myocarditis. Expression of TACE and TNF-alpha mRNAs was greater in the subgroup in New York Heart Association functional class III or IV than in the subgroup in class I or II. Expression of TACE and TNF-alpha mRNA was correlated positively with left ventricular volume (TNF-alpha: r = 0.85; TACE: r = 0.80) and negatively with left ventricular systolic function (TNF-alpha: r = -0.85; TACE: r = -0.85).
CONCLUSIONS: These findings indicate that the expression of TNF-alpha and TACE may have important implications in the pathogenesis of myocarditis and may influence advanced cardiac dysfunction in myocarditis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11028485     DOI: 10.1016/s0735-1097(00)00827-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  22 in total

Review 1.  ADAM-17: the enzyme that does it all.

Authors:  Monika Gooz
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-04       Impact factor: 8.250

2.  Degradome of soluble ADAM10 and ADAM17 metalloproteases.

Authors:  Franka Scharfenberg; Andreas Helbig; Martin Sammel; Julia Benzel; Uwe Schlomann; Florian Peters; Rielana Wichert; Maximilian Bettendorff; Dirk Schmidt-Arras; Stefan Rose-John; Catherine Moali; Stefan F Lichtenthaler; Claus U Pietrzik; Jörg W Bartsch; Andreas Tholey; Christoph Becker-Pauly
Journal:  Cell Mol Life Sci       Date:  2019-06-17       Impact factor: 9.261

3.  Brain TACE (Tumor Necrosis Factor-α-Converting Enzyme) Contributes to Sympathetic Excitation in Heart Failure Rats.

Authors:  Yang Yu; Yiling Cao; Balyssa Bell; Xiaolei Chen; Robert M Weiss; Robert B Felder; Shun-Guang Wei
Journal:  Hypertension       Date:  2019-06-03       Impact factor: 10.190

Review 4.  Disruptions and detours in the myocardial matrix highway and heart failure.

Authors:  Anne M Deschamps; Francis G Spinale
Journal:  Curr Heart Fail Rep       Date:  2005-03

Review 5.  The Role of ADAM17 in Inflammation-Related Atherosclerosis.

Authors:  Bai-Yi Tang; Jin Ge; Yang Wu; Juan Wen; Xiao-Hong Tang
Journal:  J Cardiovasc Transl Res       Date:  2022-06-01       Impact factor: 4.132

Review 6.  Immune modulation: role of the inflammatory cytokine cascade in the failing human heart.

Authors:  Mamoru Satoh; Yoshitaka Minami; Yuji Takahashi; Motoyuki Nakamura
Journal:  Curr Heart Fail Rep       Date:  2008-06

7.  Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study.

Authors:  Gregory M Marcus; Mary A Whooley; David V Glidden; Ludmila Pawlikowska; Jonathan G Zaroff; Jeffrey E Olgin
Journal:  Am Heart J       Date:  2007-10-25       Impact factor: 4.749

8.  β1-adrenergic receptor N-terminal cleavage by ADAM17; the mechanism for redox-dependent downregulation of cardiomyocyte β1-adrenergic receptors.

Authors:  Jing Zhu; Susan F Steinberg
Journal:  J Mol Cell Cardiol       Date:  2021-02-06       Impact factor: 5.000

9.  Increased levels of plasma soluble Sema4D in patients with heart failure.

Authors:  Qiongyu Lu; Ningzheng Dong; Qi Wang; Wenxiu Yi; Yuxin Wang; Shengjie Zhang; Haibo Gu; Xin Zhao; Xiaorong Tang; Boquan Jin; Qingyu Wu; Lawrence F Brass; Li Zhu
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

10.  Comparison of effects of ivabradine versus carvedilol in murine model with the Coxsackievirus B3-induced viral myocarditis.

Authors:  Li Yue-Chun; Zhang Teng; Zhou Na-Dan; Ge Li-Sha; Luo Qin; Guan Xue-Qiang; Lin Jia-Feng
Journal:  PLoS One       Date:  2012-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.